Katharine Ker

ORCID

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 10

Top Venues

BMJ open

Wellcome open research

Gates open research

Trials

London School of Hygiene and Tropical Medicine

London School of Hygiene and Tropical Medicine (MSC)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

London School of Hygiene and Tropical Medicine Oct 01 2012

United Kingdom

Assistant Professor :: Clinical Trials Unit

Education History

London School of Hygiene and Tropical Medicine

United Kingdom

MSC

Publications

Katharine Ker, Raoul Mansukhani, Haleema Shakur-Still, Monica Arribas, Danielle Beaumont, Ian Roberts
Tranexamic acid for gastrointestinal bleeding: can a reduction in the risk of death be discounted? A systematic review and meta-analysis of individual patient data from 64 724 bleeding patients. BMJ open 13 (2) (2023)
Katharine Ker, Raoul Mansukhani, Haleema Shakur-Still, Monica Arribas, Danielle Beaumont, Ian Roberts
Tranexamic acid for gastrointestinal bleeding: can a reduction in the risk of death be discounted? A systematic review and meta-analysis of individual patient data from 64 724 bleeding patients. BMJ open 13 (2) (2023)
Katharine Ker, Raoul Mansukhani, Haleema Shakur-Still, Monica Arribas, Danielle Beaumont, Ian Roberts
Tranexamic acid for gastrointestinal bleeding: can a reduction in the risk of death be discounted? A systematic review and meta-analysis of individual patient data from 64 724 bleeding patients. BMJ open 13 (2) (2023)
Katharine Ker, Raoul Mansukhani, Haleema Shakur-Still, Monica Arribas, Danielle Beaumont, Ian Roberts
Tranexamic acid for gastrointestinal bleeding: can a reduction in the risk of death be discounted? A systematic review and meta-analysis of individual patient data from 64 724 bleeding patients. BMJ open 13 (2) (2023)
Katharine Ker, Raoul Mansukhani, Haleema Shakur-Still, Monica Arribas, Danielle Beaumont, Ian Roberts
Tranexamic acid for gastrointestinal bleeding: can a reduction in the risk of death be discounted? A systematic review and meta-analysis of individual patient data from 64 724 bleeding patients. BMJ open 13 (2) (2023)
Katharine Ker, Raoul Mansukhani, Haleema Shakur-Still, Monica Arribas, Danielle Beaumont, Ian Roberts
Tranexamic acid for gastrointestinal bleeding: can a reduction in the risk of death be discounted? A systematic review and meta-analysis of individual patient data from 64 724 bleeding patients. BMJ open 13 (2) (2023)
null null, Katharine Ker, Haleema Shakur-Still, Loïc Sentilhes, Luis D Pacheco, George Saade, Catherine Deneux-Tharaux, Amy Brenner, Raoul Mansukhani, François-Xavier Ageron, Danielle Prowse, Rizwana Chaudhri, Oladapo Olayemi, Ian Roberts
Tranexamic acid for the prevention of postpartum bleeding: Protocol for a systematic review and individual patient data meta-analysis. Gates open research 7 (2023)
Jack Williams, Katharine Ker, Ian Roberts, Haleema Shakur-Still, Alec Miners
A cost-effectiveness and value of information analysis to inform future research of tranexamic acid for older adults experiencing mild traumatic brain injury. Trials 23 (1) (2022)
Katharine Ker, David Prieto-Merino, Nikola Sprigg, Abda Mahmood, Philip M Bath, Zhe Kang Law, Katie Flaherty, Ian Roberts
The effectiveness and safety of antifibrinolytics in patients with acute intracranial haemorrhage: statistical analysis plan for an individual patient data meta-analysis. Wellcome open research 2 (2017)
Katharine Ker, David Prieto-Merino, Nikola Sprigg, Abda Mahmood, Philip M Bath, Zhe Kang Law, Katie Flaherty, Ian Roberts
The effectiveness and safety of antifibrinolytics in patients with acute intracranial haemorrhage: statistical analysis plan for an individual patient data meta-analysis. Wellcome open research (2017)

Katharine Ker.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Katharine Ker